Evidence map›Paper›PMID 23884942›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

Survivin Is a transcriptional target of STAT3 critical to estradiol neuroprotection in global ischemia.

Yoshihide Sehara, Kirsty Sawicka, Jee-Yeon Hwang, Adrianna Latuszek-Barrantes, Anne M Etgen, R Suzanne Zukin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yoshihide SeharaDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Kirsty Sawicka
Jee-Yeon Hwang
Adrianna Latuszek-Barrantes
Anne M Etgen
R Suzanne Zukin
Albert Einstein College of Medicine · US

Funding

REST-Activated Program of Gene Expression in IschemiaR01NS046742 · NINDS · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI ZUKIN, R. SUZANNE · 2004 to 2019
$6.1M
Estrogen: Neuroprotection and RescueR01NS045693 · NINDS · YESHIVA UNIVERSITY · PI ZUKIN, R. SUZANNE · 2003 to 2014
$4.2M
NINDS NIH HHS NS045693NINDS NIH HHS R01 NS045693NINDS NIH HHS R01 NS046742
6 · The paper itself

Abstract

Transient global ischemia causes selective, delayed death of hippocampal CA1 pyramidal neurons in humans and animals. It is well established that estrogens ameliorate neuronal death in animal models of focal and global ischemia. However, the role of signal transducer and activator of transcription-3 (STAT3) and its target genes in estradiol neuroprotection in global ischemia remains unclear. Here we show that a single intracerebral injection of 17β-estradiol to ovariectomized female rats immediately after ischemia rescues CA1 neurons destined to die. Ischemia promotes activation of STAT3 signaling, association of STAT3 with the promoters of target genes, and STAT3-dependent mRNA and protein expression of prosurvival proteins in the selectively vulnerable CA1. In animals subjected to ischemia, acute postischemic estradiol further enhances activation and nuclear translocation of STAT3 and STAT3-dependent transcription of target genes. Importantly, we show that STAT3 is critical to estradiol neuroprotection, as evidenced by the ability of STAT3 inhibitor peptide and STAT3 shRNA delivered directly into the CA1 of living animals to abolish neuroprotection. In addition, we identify survivin, a member of the inhibitor-of-apoptosis family of proteins and known gene target of STAT3, as essential to estradiol neuroprotection, as evidenced by the ability of shRNA to survivin to reverse neuroprotection. These findings indicate that ischemia and estradiol act synergistically to promote activation of STAT3 and STAT3-dependent transcription of survivin in insulted CA1 neurons and identify STAT3 and survivin as potentially important therapeutic targets in an in vivo model of global ischemia.

Indexed as

Active Transport, Cell NucleusAnimalsBrain IschemiaCA1 Region, HippocampalCell SurvivalEstradiolFemaleInjections, IntraventricularMicrotubule-Associated ProteinsNeuronsNeuroprotective AgentsOvariectomyPhosphorylationRatsRats, Sprague-DawleyRNA, Small InterferingBirc5 protein, ratEstradiolMicrotubule-Associated ProteinsNeuroprotective AgentsRNA, Small InterferingStat3 protein, ratSTAT3 Transcription FactorSurvivin

Identifiers

PMID23884942
PMCPMC3721844
OpenAlexW1981840506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.